vs
MidWestOne Financial Group, Inc.（MOFG）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是MidWestOne Financial Group, Inc.的1.1倍（$69.8M vs $61.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 27.8%，领先356.3%），MidWestOne Financial Group, Inc.同比增速更快（35.9% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 37.2%）
中西部一号金融集团是一家银行控股公司，总部位于美国爱荷华城。集团旗下共运营56家分行，是总部设于爱荷华州的第三大银行，业务覆盖爱荷华州、明尼苏达州、威斯康星州、科罗拉多州以及佛罗里达州。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MOFG vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$61.3M
营收增速更快
MOFG
高出14.8%
21.2%
净利率更高
RIGL
高出356.3%
27.8%
两年增速更快
RIGL
近两年复合增速
37.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.3M | $69.8M |
| 净利润 | $17.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 35.1% | 33.2% |
| 净利率 | 27.8% | 384.0% |
| 营收同比 | 35.9% | 21.2% |
| 净利润同比 | 117.8% | 1769.2% |
| 每股收益（稀释后） | $0.82 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOFGRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $61.3M | $69.5M | ||
| Q2 25 | $60.2M | $101.7M | ||
| Q1 25 | $57.6M | $53.3M | ||
| Q4 24 | $48.9M | $57.6M | ||
| Q3 24 | $37.5M | $55.3M | ||
| Q2 24 | $57.9M | $36.8M | ||
| Q1 24 | $44.5M | $29.5M |
净利润MOFGRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $17.0M | $27.9M | ||
| Q2 25 | $10.0M | $59.6M | ||
| Q1 25 | $15.1M | $11.4M | ||
| Q4 24 | $16.3M | $14.3M | ||
| Q3 24 | $-95.7M | $12.4M | ||
| Q2 24 | $15.8M | $-1.0M | ||
| Q1 24 | $3.3M | $-8.2M |
毛利率MOFGRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率MOFGRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | 35.1% | 40.9% | ||
| Q2 25 | 20.9% | 60.1% | ||
| Q1 25 | 34.0% | 23.9% | ||
| Q4 24 | 43.1% | 28.9% | ||
| Q3 24 | -347.0% | 25.4% | ||
| Q2 24 | 36.0% | 1.2% | ||
| Q1 24 | 9.5% | -23.6% |
净利率MOFGRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 27.8% | 40.2% | ||
| Q2 25 | 16.6% | 58.6% | ||
| Q1 25 | 26.3% | 21.5% | ||
| Q4 24 | 33.4% | 24.9% | ||
| Q3 24 | -255.1% | 22.5% | ||
| Q2 24 | 27.3% | -2.8% | ||
| Q1 24 | 7.3% | -27.9% |
每股收益（稀释后）MOFGRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.82 | $1.46 | ||
| Q2 25 | $0.48 | $3.28 | ||
| Q1 25 | $0.73 | $0.63 | ||
| Q4 24 | $1.30 | $0.82 | ||
| Q3 24 | $-6.05 | $0.70 | ||
| Q2 24 | $1.00 | $-0.06 | ||
| Q1 24 | $0.21 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $98.0M | $52.5M |
| 股东权益账面价值 | $606.1M | $391.5M |
| 总资产 | $6.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.16× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MOFGRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务MOFGRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $98.0M | $60.0M | ||
| Q2 25 | $112.3M | $60.0M | ||
| Q1 25 | $111.4M | $60.0M | ||
| Q4 24 | $113.4M | $60.0M | ||
| Q3 24 | $115.1M | $60.0M | ||
| Q2 24 | $114.8M | $60.0M | ||
| Q1 24 | $122.1M | $60.0M |
股东权益MOFGRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $606.1M | $117.6M | ||
| Q2 25 | $589.0M | $81.9M | ||
| Q1 25 | $579.6M | $18.6M | ||
| Q4 24 | $559.7M | $3.3M | ||
| Q3 24 | $562.2M | $-14.6M | ||
| Q2 24 | $543.3M | $-29.9M | ||
| Q1 24 | $528.0M | $-31.7M |
总资产MOFGRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $6.2B | $242.5M | ||
| Q2 25 | $6.2B | $206.7M | ||
| Q1 25 | $6.3B | $176.0M | ||
| Q4 24 | $6.2B | $164.0M | ||
| Q3 24 | $6.6B | $139.4M | ||
| Q2 24 | $6.6B | $128.4M | ||
| Q1 24 | $6.7B | $126.5M |
负债/权益比MOFGRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.16× | 0.51× | ||
| Q2 25 | 0.19× | 0.73× | ||
| Q1 25 | 0.19× | 3.23× | ||
| Q4 24 | 0.20× | 18.25× | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $16.7M | — |
| 自由现金流率自由现金流/营收 | 27.3% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | 1.04× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $109.6M | — |
8季度趋势，按日历期对齐
经营现金流MOFGRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $17.7M | $24.0M | ||
| Q2 25 | $24.9M | $30.5M | ||
| Q1 25 | $8.7M | $-893.0K | ||
| Q4 24 | $63.2M | $14.5M | ||
| Q3 24 | $-2.8M | $21.7M | ||
| Q2 24 | $25.2M | $302.0K | ||
| Q1 24 | $9.6M | $-5.0M |
自由现金流MOFGRIGL
| Q4 25 | — | — | ||
| Q3 25 | $16.7M | — | ||
| Q2 25 | $23.8M | — | ||
| Q1 25 | $8.3M | — | ||
| Q4 24 | $60.8M | — | ||
| Q3 24 | $-3.0M | — | ||
| Q2 24 | $24.6M | — | ||
| Q1 24 | $9.1M | — |
自由现金流率MOFGRIGL
| Q4 25 | — | — | ||
| Q3 25 | 27.3% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 124.2% | — | ||
| Q3 24 | -7.9% | — | ||
| Q2 24 | 42.5% | — | ||
| Q1 24 | 20.4% | — |
资本支出强度MOFGRIGL
| Q4 25 | — | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 1.2% | — |
现金转化率MOFGRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.04× | 0.86× | ||
| Q2 25 | 2.50× | 0.51× | ||
| Q1 25 | 0.57× | -0.08× | ||
| Q4 24 | 3.87× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 1.60× | — | ||
| Q1 24 | 2.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
